Redwood Investment Management LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 4,933 shares of the company’s stock, valued at approximately $634,000.
Several other institutional investors and hedge funds also recently made changes to their positions in MKGAF. Frazier Financial Advisors LLC acquired a new stake in Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new position in Merck KGaA in the second quarter valued at approximately $27,000. Solstein Capital LLC acquired a new position in Merck KGaA in the second quarter valued at approximately $33,000. Delos Wealth Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC bought a new position in shares of Merck KGaA during the 2nd quarter worth approximately $39,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of MKGAF stock opened at $158.15 on Friday. The firm has a 50 day moving average of $163.21 and a 200-day moving average of $148.95. The company has a market cap of $20.44 billion, a price-to-earnings ratio of 24.14 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
